Correlation Between Cytokinetics and Nurix Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytokinetics and Nurix Therapeutics, you can compare the effects of market volatilities on Cytokinetics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Nurix Therapeutics.

Diversification Opportunities for Cytokinetics and Nurix Therapeutics

0.75

Correlation Coefficient

Cytokinetics  Nurix Therapeutics

Poor diversification

The 3 months correlation between Cytokinetics and Nurix is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Cytokinetics i.e., Cytokinetics and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Cytokinetics and Nurix Therapeutics

Given the investment horizon of 90 days Cytokinetics is expected to under-perform the Nurix Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cytokinetics is 1.67 times less risky than Nurix Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Nurix Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  2,006  in Nurix Therapeutics on October 6, 2024 and sell it today you would lose (55.00) from holding Nurix Therapeutics or give up 2.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cytokinetics  vs.  Nurix Therapeutics

Cytokinetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Nurix Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Nurix Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cytokinetics and Nurix Therapeutics

The main advantage of trading using opposite Cytokinetics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.

The idea behind Cytokinetics and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.